Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia

Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia

US Patent 12036210 · Granted Jul 16, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Highly structured porous silica materials and biological uses thereof2025
Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglyca2025
Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglyca2025
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglyc2025
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglyc2025
Porous silica material for use as a pharmaceutical or dietary active ingredient2024
Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia2023
Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia2023
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglyc2023
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglyc2023
Electric friction drive device and electric drive system2023
Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemi2022